546 related articles for article (PubMed ID: 15596754)
1. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.
Sevigny JJ; Albert SM; McDermott MP; Schifitto G; McArthur JC; Sacktor N; Conant K; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Marder K; Epstein LG
Arch Neurol; 2007 Jan; 64(1):97-102. PubMed ID: 17210815
[TBL] [Abstract][Full Text] [Related]
3. Markers of immune activation and viral load in HIV-associated sensory neuropathy.
Schifitto G; McDermott MP; McArthur JC; Marder K; Sacktor N; McClernon DR; Conant K; Cohen B; Epstein LG; Kieburtz K;
Neurology; 2005 Mar; 64(5):842-8. PubMed ID: 15753420
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.
Chang L; Ernst T; St Hillaire C; Conant K
Antivir Ther; 2004 Jun; 9(3):431-40. PubMed ID: 15259906
[TBL] [Abstract][Full Text] [Related]
5. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
McArthur JC; McDermott MP; McClernon D; St Hillaire C; Conant K; Marder K; Schifitto G; Selnes OA; Sacktor N; Stern Y; Albert SM; Kieburtz K; deMarcaida JA; Cohen B; Epstein LG
Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180
[TBL] [Abstract][Full Text] [Related]
6. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
[TBL] [Abstract][Full Text] [Related]
7. Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients.
Larussa D; Lorenzini P; Cingolani A; Bossolasco S; Grisetti S; Bongiovanni M; Moretti F; Uccella I; Zannoni P; Foresti S; Mazzarello G; Arcidiacono MI; Pedale R; Ammassari A; Tozzi V; Perno CF; Monforte AD; Cinque P; Antinori A;
AIDS Res Hum Retroviruses; 2006 May; 22(5):386-92. PubMed ID: 16706614
[TBL] [Abstract][Full Text] [Related]
8. Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection.
Lentz MR; Degaonkar M; Mohamed MA; Kim H; Conant K; Halpern EF; Sacktor N; Barker PB; Pomper MG
J Neurovirol; 2010 Oct; 16(5):368-76. PubMed ID: 20839921
[TBL] [Abstract][Full Text] [Related]
9. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
[TBL] [Abstract][Full Text] [Related]
10. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.
Monteiro de Almeida S; Letendre S; Zimmerman J; Lazzaretto D; McCutchan A; Ellis R
J Neuroimmunol; 2005 Dec; 169(1-2):144-52. PubMed ID: 16182380
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation.
Airoldi M; Bandera A; Trabattoni D; Tagliabue B; Arosio B; Soria A; Rainone V; Lapadula G; Annoni G; Clerici M; Gori A
Clin Dev Immunol; 2012; 2012():467154. PubMed ID: 22489249
[TBL] [Abstract][Full Text] [Related]
13. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
Bogoch II; Davis BT; Venna N
J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
[TBL] [Abstract][Full Text] [Related]
14. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
[TBL] [Abstract][Full Text] [Related]
15. Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.
Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Kumar M
J Neurovirol; 2009 Jan; 15(1):25-35. PubMed ID: 19031329
[TBL] [Abstract][Full Text] [Related]
16. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
17. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
[TBL] [Abstract][Full Text] [Related]
18. Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration.
Eggers C; Hertogs K; Stürenburg HJ; van Lunzen J; Stellbrink HJ
AIDS; 2003 Sep; 17(13):1897-906. PubMed ID: 12960822
[TBL] [Abstract][Full Text] [Related]
19. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.
Childs EA; Lyles RH; Selnes OA; Chen B; Miller EN; Cohen BA; Becker JT; Mellors J; McArthur JC
Neurology; 1999 Feb; 52(3):607-13. PubMed ID: 10025796
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
Christo PP; Greco DB; Aleixo AW; Livramento JA
BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
